DYOR. It's got a moat, being the only 100% bioabsorbable dermal matrix.
It's got a profit margin of 90%+, despite selling its product for as much as half that as competitors to get a foothold in the market.
PNV last raised capital back in 2017, and despite the impact of covid storm - has not had to raise any additional cash.
It's not yet an 'industry staple', but it's well on the path there if you dyor and hear from surgeons and hospitals that have adopted BTM and subsequently dropped the use of biological matrices altogether. You could wait for it to become an industry staple if, but be prepared to pay a lot more for it at that point.
Good luck with your research.
PNV - Banter and General Comments, page-7754
-
- There are more pages in this discussion • 4,255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |